Offer - Urjas Oil for just ₹ 1 X
Acutrol C 400 Tablet is a prescription medicine that is available as a Tablet. It is typically used for the treatment of Increased Phosphate Levels in the Blood. The alternative uses of Acutrol C 400 Tablet have also been explained below.
The right dosage of Acutrol C 400 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Some other side effects of Acutrol C 400 Tablet have been listed ahead. Usually, these side effects of Acutrol C 400 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Acutrol C 400 Tablet's effect during pregnancy is Unknown and Safe while nursing. Warnings related to Acutrol C 400 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Intestinal Obstruction must refrain from the use of Acutrol C 400 Tablet since this can cause severe adverse effects. The section on Acutrol C 400 Tablet contraindications lists all such conditions.
Drug interactions for Acutrol C 400 Tablet have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Acutrol C 400 Tablet is considered safe while driving, and is addictive.
Acutrol C 400 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Is the use of Acutrol C 400 Tablet safe for pregnant women?
It is not known what effect Acutrol C will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Acutrol C 400 Tablet safe during breastfeeding?
Acutrol C does not show any harmful effects in lactating women.
What is the effect of Acutrol C 400 Tablet on the Kidneys?
Very few cases of side effects of Acutrol C on kidney have been reported.
What is the effect of Acutrol C 400 Tablet on the Liver?
Information about safety of Acutrol C for the liver is not available since scientific research on this is yet to be done.
What is the effect of Acutrol C 400 Tablet on the Heart?
In the absence of any scientific study on the side effects of Acutrol C on the heart, information on safety of Acutrol C for the heart is unavailable.
If you are suffering from any of the following diseases, you should not take Acutrol C 400 Tablet unless your doctor advises you to do so -
Is this Acutrol C 400 Tablet habit forming or addictive?
No, you will not get addicted to Acutrol C 400 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Acutrol C 400 Tablet since it does not cause drowsiness.
Is it safe?
Acutrol C 400 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Acutrol C 400 Tablet for mental disorders.
Interaction between Food and Acutrol C 400 Tablet
There is no information on the effects of taking Acutrol C 400 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Acutrol C 400 Tablet
It is difficult to say anything about the effect of Acutrol C 400 Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renvela (sevelamer carbonate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1134-1135